Smart for Life (SMFL) Competitors $0.0023 -0.02 (-90.50%) As of 07/28/2025 03:44 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMFL vs. SYRS, VIRX, NCNA, CAPS, VINC, BON, MYMD, UPC, VRPX, and SCPSShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Syros Pharmaceuticals (SYRS), Viracta Therapeutics (VIRX), NuCana (NCNA), Capstone Therapeutics (CAPS), Vincerx Pharma (VINC), Bon Natural Life (BON), MyMD Pharmaceuticals (MYMD), Universe Pharmaceuticals (UPC), Virpax Pharmaceuticals (VRPX), and Scopus BioPharma (SCPS). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Its Competitors Syros Pharmaceuticals Viracta Therapeutics NuCana Capstone Therapeutics Vincerx Pharma Bon Natural Life MyMD Pharmaceuticals Universe Pharmaceuticals Virpax Pharmaceuticals Scopus BioPharma Smart for Life (NASDAQ:SMFL) and Syros Pharmaceuticals (NASDAQ:SYRS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations. Which has more volatility & risk, SMFL or SYRS? Smart for Life has a beta of 17.24, suggesting that its share price is 1,624% more volatile than the S&P 500. Comparatively, Syros Pharmaceuticals has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500. Do analysts rate SMFL or SYRS? Syros Pharmaceuticals has a consensus price target of $3.33, suggesting a potential upside of 302,930.30%. Given Syros Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Syros Pharmaceuticals is more favorable than Smart for Life.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smart for Life 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Syros Pharmaceuticals 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Is SMFL or SYRS more profitable? Smart for Life's return on equity of 0.00% beat Syros Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Syros Pharmaceuticals N/A -3,369.56%-97.04% Which has stronger earnings and valuation, SMFL or SYRS? Smart for Life has higher revenue and earnings than Syros Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.00-$22.68MN/AN/ASyros Pharmaceuticals$386K0.08-$164.57M-$3.030.00 Does the media favor SMFL or SYRS? In the previous week, Syros Pharmaceuticals had 1 more articles in the media than Smart for Life. MarketBeat recorded 1 mentions for Syros Pharmaceuticals and 0 mentions for Smart for Life. Smart for Life's average media sentiment score of 0.00 equaled Syros Pharmaceuticals'average media sentiment score. Company Overall Sentiment Smart for Life Neutral Syros Pharmaceuticals Neutral Do institutionals & insiders have more ownership in SMFL or SYRS? 28.4% of Smart for Life shares are held by institutional investors. Comparatively, 91.5% of Syros Pharmaceuticals shares are held by institutional investors. 31.7% of Smart for Life shares are held by insiders. Comparatively, 12.3% of Syros Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummarySmart for Life and Syros Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$16K$3.44B$5.70B$9.56BDividend YieldN/AN/A4.71%4.06%P/E RatioN/A7.6328.1919.94Price / Sales0.0027.08461.9396.03Price / CashN/A5.6236.3258.72Price / Book0.001.118.295.77Net Income-$22.68M$17.44M$3.25B$259.21M7 Day PerformanceN/A-0.80%0.21%-0.80%1 Month PerformanceN/A6.30%8.71%9.81%1 Year PerformanceN/A-29.22%32.76%14.37% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.00-90.5%N/A-99.9%$16K$11.11M0.00110Gap UpHigh Trading VolumeSYRSSyros Pharmaceuticals4.099 of 5 stars$0.02+471.4%$3.33+16,566.7%-99.8%$537K$386K-0.01120Gap UpVIRXViracta Therapeutics1.9723 of 5 stars$0.01flat$1.75+17,793.7%N/A$389KN/A-0.0120News CoverageNCNANuCana3.2677 of 5 stars$0.05+3.9%$25.00+47,069.8%-98.6%$310KN/A-0.0130Gap UpHigh Trading VolumeCAPSCapstone TherapeuticsN/A$1.60-1.2%N/AN/A$260K$44.88M0.0038Positive NewsVINCVincerx Pharma2.629 of 5 stars$0.06+15.2%$40.00+70,075.4%-99.7%$259KN/A0.0060Gap DownBONBon Natural LifeN/A$1.44+1.4%N/A-97.3%$240K$23.84M0.00100MYMDMyMD PharmaceuticalsN/A$0.09-7.6%N/A-93.9%$207KN/A0.006Gap DownHigh Trading VolumeUPCUniverse PharmaceuticalsN/A$3.76+7.9%N/A-99.8%$161K$19.29M0.00220VRPXVirpax PharmaceuticalsN/A$0.06-81.9%N/A-99.8%$74KN/A0.007Gap DownSCPSScopus BioPharmaN/A$0.00flatN/AN/A$13KN/A0.009 Related Companies and Tools Related Companies Syros Pharmaceuticals Competitors Viracta Therapeutics Competitors NuCana Competitors Capstone Therapeutics Competitors Vincerx Pharma Competitors Bon Natural Life Competitors MyMD Pharmaceuticals Competitors Universe Pharmaceuticals Competitors Virpax Pharmaceuticals Competitors Scopus BioPharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMFL) was last updated on 7/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
